The role of lysosome in regulated necrosis

被引:72
作者
Alu, Aqu [1 ]
Han, Xuejiao [1 ]
Ma, Xuelei [1 ]
Wu, Min [2 ]
Wei, Yuquan [1 ]
Wei, Xiawei [1 ]
机构
[1] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Aging Res & Canc Drug Target,State Key Lab Bi, Chengdu 610041, Peoples R China
[2] Univ North Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA
关键词
Ferroptosis; Lysosome; Necroptosis; Pyroptosis; Regulated necrosis; NLRP3 INFLAMMASOME ACTIVATION; NEUTROPHIL EXTRACELLULAR TRAPS; PIGMENT EPITHELIAL-CELLS; ISCHEMIC NEURONAL DEATH; MIXED LINEAGE KINASE; CATHEPSIN-B RELEASE; DOMAIN-LIKE PROTEIN; MEMBRANE PERMEABILIZATION; CANCER-CELLS; OXIDATIVE STRESS;
D O I
10.1016/j.apsb.2020.07.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lysosome is a ubiquitous acidic organelle fundamental for the turnover of unwanted cellular molecules, particles, and organelles. Currently, the pivotal role of lysosome in regulating cell death is drawing great attention. Over the past decades, we largely focused on how lysosome influences apoptosis and autophagic cell death. However, extensive studies showed that lysosome is also prerequisite for the execution of regulated necrosis (RN). Different types of RN have been uncovered, among which, necroptosis, ferroptosis, and pyroptosis are under the most intensive investigation. It becomes a hot topic nowadays to target RN as a therapeutic intervention, since it is important in many patho/physiological settings and contributing to numerous diseases. It is promising to target lysosome to control the occurrence of RN thus altering the outcomes of diseases. Therefore, we aim to give an introduction about the common factors influencing lysosomal stability and then summarize the current knowledge on the role of lysosome in the execution of RN, especially in that of necroptosis, ferroptosis, and pyroptosis. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:1880 / 1903
页数:24
相关论文
共 318 条
[71]   Flotillin-mediated endocytosis and ALIX-syntenin-1-mediated exocytosis protect the cell membrane from damage caused by necroptosis [J].
Fan, Weiliang ;
Guo, Jia ;
Gao, Beichen ;
Zhang, Wenbin ;
Ling, Liucong ;
Xu, Tao ;
Pan, Chenjie ;
Li, Lin ;
Chen, She ;
Wang, Hua ;
Zhang, Jing ;
Wang, Xiaodong .
SCIENCE SIGNALING, 2019, 12 (583)
[72]   The AIM2 inflammasome is critical for innate immunity to Francisella tularensis [J].
Fernandes-Alnemri, Teresa ;
Yu, Je-Wook ;
Juliana, Christine ;
Solorzano, Leobaldo ;
Kang, Seokwon ;
Wu, Jianghong ;
Datta, Pinaki ;
McCormick, Margaret ;
Huang, Lan ;
McDermott, Erin ;
Eisenlohr, Laurence ;
Landel, Carlisle P. ;
Alnemri, Emad S. .
NATURE IMMUNOLOGY, 2010, 11 (05) :385-394
[73]   Organelle-specific initiation of cell death pathways [J].
Ferri, KF ;
Kroemer, G .
NATURE CELL BIOLOGY, 2001, 3 (11) :E255-E263
[74]   Novel cell death program leads to neutrophil extracellular traps [J].
Fuchs, Tobias A. ;
Abed, Ulrike ;
Goosmann, Christian ;
Hurwitz, Robert ;
Schulze, Ilka ;
Wahn, Volker ;
Weinrauch, Yvette ;
Brinkmann, Volker ;
Zychlinsky, Arturo .
JOURNAL OF CELL BIOLOGY, 2007, 176 (02) :231-241
[75]   Targeting cyclophilin D and the mitochondrial permeability transition enhances β-cell survival and prevents diabetes in Pdx1 deficiency [J].
Fujimoto, Kei ;
Chen, Yun ;
Polonsky, Kenneth S. ;
Dorn, Gerald W., II .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (22) :10214-10219
[76]   Therapeutic exploitation of necroptosis for cancer therapy [J].
Fulda, Simone .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 35 :51-56
[77]   The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3 [J].
Gaidt, Moritz M. ;
Ebert, Thomas S. ;
Chauhan, Dhruv ;
Ramshorn, Katharina ;
Pinci, Francesca ;
Zuber, Sarah ;
O'Duill, Fionan ;
Schmid-Burgk, Jonathan L. ;
Hoss, Florian ;
Buhmann, Raymund ;
Wittmann, Georg ;
Latz, Eicke ;
Subklewe, Marion ;
Hornung, Veit .
CELL, 2017, 171 (05) :1110-+
[78]   Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 [J].
Galluzzi, L. ;
Vitale, I. ;
Abrams, J. M. ;
Alnemri, E. S. ;
Baehrecke, E. H. ;
Blagosklonny, M. V. ;
Dawson, T. M. ;
Dawson, V. L. ;
El-Deiry, W. S. ;
Fulda, S. ;
Gottlieb, E. ;
Green, D. R. ;
Hengartner, M. O. ;
Kepp, O. ;
Knight, R. A. ;
Kumar, S. ;
Lipton, S. A. ;
Lu, X. ;
Madeo, F. ;
Malorni, W. ;
Mehlen, P. ;
Nunez, G. ;
Peter, M. E. ;
Piacentini, M. ;
Rubinsztein, D. C. ;
Shi, Y. ;
Simon, H-U ;
Vandenabeele, P. ;
White, E. ;
Yuan, J. ;
Zhivotovsky, B. ;
Melino, G. ;
Kroemer, G. .
CELL DEATH AND DIFFERENTIATION, 2012, 19 (01) :107-120
[79]   Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 [J].
Galluzzi, Lorenzo ;
Vitale, Ilio ;
Aaronson, Stuart A. ;
Abrams, John M. ;
Adam, Dieter ;
Agostinis, Patrizia ;
Alnemri, Emad S. ;
Altucci, Lucia ;
Amelio, Ivano ;
Andrews, David W. ;
Annicchiarico-Petruzzelli, Margherita ;
Antonov, Alexey V. ;
Arama, Eli ;
Baehrecke, Eric H. ;
Barlev, Nickolai A. ;
Bazan, Nicolas G. ;
Bernassola, Francesca ;
Bertrand, Mathieu J. M. ;
Bianchi, Katiuscia ;
Blagosklonny, Mikhail V. ;
Blomgren, Klas ;
Borner, Christoph ;
Boya, Patricia ;
Brenner, Catherine ;
Campanella, Michelangelo ;
Candi, Eleonora ;
Carmona-Gutierrez, Didac ;
Cecconi, Francesco ;
Chan, Francis K. -M. ;
Chandel, Navdeep S. ;
Cheng, Emily H. ;
Chipuk, Jerry E. ;
Cidlowski, John A. ;
Ciechanover, Aaron ;
Cohen, Gerald M. ;
Conrad, Marcus ;
Cubillos-Ruiz, Juan R. ;
Czabotar, Peter E. ;
D'Angiolella, Vincenzo ;
Dawson, Ted M. ;
Dawson, Valina L. ;
De laurenzi, Vincenzo ;
De Maria, Ruggero ;
Debatin, Klaus-Michael ;
DeBerardinis, Ralph J. ;
Deshmukh, Mohanish ;
Di Daniele, Nicola ;
Di Virgilio, Francesco ;
Dixit, Vishva M. ;
Dixon, Scott J. .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (03) :486-541
[80]   MLKL regulates necrotic plasma membrane permeabilization [J].
Galluzzi, Lorenzo ;
Kepp, Oliver ;
Kroemer, Guido .
CELL RESEARCH, 2014, 24 (02) :139-140